GMP-Source® Gene Synthesis for Neoantigen Therapeutics Production
Designed to meet the needs of rapid gene synthesis for novel cancer treatments based on neoantigens, this service enables clients to have an end-to-end clinical manufacturing production process that meets their compliance and timeline requirements as well as protects their intellectual property.
- Rapid turnaround time
- Segregated manufacturing environment
- Raw material and process traceability
We also offer standard research gene synthesis services for your plasmid production projects. For more information please see our Full-Service Gene Synthesis page.